FXR primes the liver for intestinal FGF15 signaling by transient induction of β-Klotho

Molecular Endocrinology

Volumn 30, Issue 1, 2016, Pages 92-103

  Fu, Ting ^a   Kim, Young Chae ^a   Byun, Sangwon ^a   Kim, Dong Hyun ^a   Seok, Sunmi ^a   Suino Powell, Kelly ^b   Eric Xu, H ^b,c   Kemper, Byron ^a   Kemper, Jongsook Kim ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^b VAN ANDEL RESEARCH INSTITUTE   (United States)

^c SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

[No Author keywords available]

Indexed keywords

3 [2 [2 CHLORO 4 [3 (2,6 DICHLOROPHENYL) 5 ISOPROPYL 4 ISOXAZOLYLMETHOXY]PHENYL]VINYL]BENZOIC ACID; CELL RECEPTOR; FARNESOID X-ACTIVATED RECEPTOR; FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 15, MOUSE; ISOXAZOLE DERIVATIVE; KLB PROTEIN, MOUSE; MEMBRANE PROTEIN;

AGONISTS; ANIMAL; DRUG EFFECTS; GENETICS; INTESTINE; KNOCKOUT MOUSE; LIVER; LIVER CELL; METABOLISM; MOUSE; PHOSPHORYLATION; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; FIBROBLAST GROWTH FACTORS; HEPATOCYTES; INTESTINES; ISOXAZOLES; LIVER; MEMBRANE PROTEINS; MICE; MICE, KNOCKOUT; PHOSPHORYLATION; RECEPTORS, CYTOPLASMIC AND NUCLEAR; SIGNAL TRANSDUCTION;

EID: 84953246394     PISSN: 08888809     EISSN: 19449917     Source Type: Journal    
DOI: 10.1210/me.2015-1226     Document Type: Article

References (37)

1. Kliewer SA, Mangelsdorf DJ. Bile acids as hormones: the FXRFGF15/19 pathway. Dig Dis. 2015;33:327-331
2. de Aguiar Vallim TQ, Tarling EJ, Edwards PA. Pleiotropic roles of bile acids in metabolism. Cell Metab. 2013;17:657-669
3. Chiang JY. Bile acid metabolism and signaling. Compr Physiol. 2013;3:1191-1212
4. Hylemon PB, Zhou H, Pandak WM, Ren S, Gil G, Dent P. Bile acids as regulatory molecules. J Lipid Res. 2009;50:1509-1520
5. Chiang JY. Bile acids: regulation of synthesis. J Lipid Res. 2009;50: 1955-1966
6. Thomas C, Pellicciari R, Pruzanski M, Auwerx J, Schoonjans K. Targeting bile-acid signalling for metabolic diseases. Nat Rev Drug Discov. 2008;7:678-693
7. Angelin B, Björkhem I, Einarsson K, Ewerth S. Hepatic uptake of bile acids in man. Fasting and postprandial concentrations of individual bile acids in portal venous and systemic blood serum. J Clin Invest. 1982;70:724-731
8. Calkin AC, Tontonoz P. Transcriptional integration of metabolism by the nuclear sterol-activated receptors LXR and FXR. Nat Rev Mol Cell Biol. 2012;13:213-224
9. Matsubara T, Li F, Gonzalez FJ. FXR signaling in the enterohepatic system. Mol Cell Endocrinol. 2013;368:17-29
10. Inagaki T, Choi M, Moschetta A, et al. Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis. Cell Metab. 2005;2:217-225
11. Katafuchi T, Esterházy D, Lemoff A, et al. Detection of FGF15 in plasma by stable isotope standards and capture by anti-peptide antibodies and targeted mass spectrometry. Cell Metab. 2015;21: 898-904
12. Lin BC, Wang M, Blackmore C, Desnoyers LR. Liver-specific activities of FGF19 require Klotho β. J Biol Chem. 2007;282:27277-27284
13. Kurosu H, Choi M, Ogawa Y, et al. Tissue-specific expression of β Klotho and fibroblast growth factor (FGF) receptor isoforms determines metabolic activity of FGF19 and FGF21. J Biol Chem. 2007;282:26687-26695
14. Kir S, Beddow SA, Samuel VT, et al. FGF19 as a postprandial, insulin-independent activator of hepatic protein and glycogen synthesis. Science. 2011;331:1621-1624
15. Li S, Hsu DD, Li B, et al. Cytoplasmic tyrosine phosphatase Shp2 coordinates hepatic regulation of bile acid and FGF15/19 signaling to repress bile acid synthesis. Cell Metab. 2014;20:320-332
16. Yu C, Wang F, Kan M, et al. Elevated cholesterol metabolism and bile acid synthesis in mice lacking membrane tyrosine kinase receptor FGFR4. J Biol Chem. 2000;275:15482-15489
17. Ito S, Fujimori T, Furuya A, Satoh J, Nabeshima Y. Impaired negative feedback suppression of bile acid synthesis in mice lacking β Klotho. J Clin Invest. 2005;115:2202-2208
18. Tomiyama K, Maeda R, Urakawa I, et al. Relevant use of Klotho in FGF19 subfamily signaling system in vivo. Proc Natl Acad Sci USA. 2010;107:1666-1671
19. Lee J, Seok SM, Yu P, et al. Genomic analysis of hepatic Farnesoid X Receptor (FXR) binding sites reveals altered binding in obesity and direct gene repression by FXR. Hepatol. 2012;56:108-117
20. Fu T, Choi SE, Kim DH, et al. Aberrantly elevated microRNA-34a in obesity attenuates hepatic responses to FGF19 by targeting a membrane coreceptor β-Klotho. Proc Natl Acad Sci USA. 2012; 109:16137-16142
21. Fu T, Seok S, Choi S, et al. MicroRNA 34a inhibits beige and brown fat formation in obesity in part by suppressing adipocyte fibroblast growth factor 21 signaling and SIRT1 function. Mol Cell Biol. 2014;34:4130-4142
22. Sinal CJ, Tohkin M, Miyata M, Ward JM, Lambert G, Gonzalez FJ. Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis. Cell. 2000;102:731-744
23. Maloney PR, Parks DJ, Haffner CD, et al. Identification of a chemical tool for the orphan nuclear receptor FXR. J Med Chem. 2000; 43:2971-2974
24. Maruyama T, Miyamoto Y, Nakamura T, et al. Identification of membrane-type receptor for bile acids (M-BAR). Biochem Biophys Res Commun. 2002;298:714-719
25. Studer E, Zhou X, Zhao R, et al. Conjugated bile acids activate the sphingosine-1-phosphate receptor 2 in primary rodent hepatocytes. Hepatology. 2012;55:267-276
26. Kong B, Wang L, Chiang JY, Zhang Y, Klaassen CD, Guo GL. Mechanism of tissue-specific farnesoid X receptor in suppressing the expression of genes in bile-acid synthesis in mice. Hepatology. 2012;56:1034-1043
27. Song KH, Li T, Owsley E, Strom S, Chiang JY. Bile acids activate fibroblast growth factor 19 signaling in human hepatocytes to inhibit cholesterol 7-hydroxylase gene expression. Hepatology. 2009;49:297-305
28. Lundåsen T, Gälman C, Angelin B, Rudling M. Circulating intestinal fibroblast growth factor 19 has a pronounced diurnal variation and modulates hepatic bile acid synthesis in man. J Intern Med. 2006;260:530-536
29. Lin BC, Desnoyers LR. FGF19 and cancer. Adv Exp Med Biol. 2012;728:183-194
30. Gupta S, Stravitz RT, Dent P, Hylemon PB. Down-regulation of cholesterol 7 a-hydroxylase (CYP7A1) gene expression by bile acids in primary rat hepatocytes is mediated by the c-jun N-terminal kinase pathway. J Biol Chem. 2001;276:15816-15822
31. Li T, Jahan A, Chiang JY. Bile acids and cytokines inhibit the human cholesterol 7-hydroxylase gene via the JNK/c-jun pathway in human liver cells. Hepatology. 2006;43:1202-1210
32. Yu C, Wang F, Jin C, Huang X, McKeehan WL. Independent repression of bile acid synthesis and activation of c-Jun N-terminal kinase (JNK) by activated hepatocyte fibroblast growth factor receptor 4 (FGFR4) and bile acids. J Biol Chem. 2005;280:17707-17714
33. Ponugoti B, Fang S, Kemper JK. Functional interaction of HNF-4 and PGC-1 in CYP7A1 regulation is inhibited by a key lipogenic activator, SREBP-1c. Mol Endocrinol. 2007;21:2698-2712
34. Kim I, Ahn SH, Inagaki T, et al. Differential regulation of bile acid homeostasis by the farnesoid X receptor in liver and intestine. J Lipid Res. 2007;48:2664-2672
35. Potthoff MJ, Boney-Montoya J, Choi M, et al. FGF15/19 regulates hepatic glucose metabolism by inhibiting the CREB-PGC-1 pathway. Cell Metab. 2011;13:729-738
36. de Aguiar Vallim TQ, Tarling EJ, Ahn H, et al. MAFG is a transcriptional repressor of bile acid synthesis and metabolism. Cell Metab. 2015;21:298-310
37. Kim YC, Fang S, Byun S, Seok S, Kemper B, Kemper JK FX. R-induced lysine-specific histone demethylase, LSD1, reduces hepatic bile acid levels and protects the liver against bile acid toxicity. Hepatology. 2015;62:231